These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 28837596)

  • 1. Membrane-active macromolecules kill antibiotic-tolerant bacteria and potentiate antibiotics towards Gram-negative bacteria.
    Uppu DSSM; Konai MM; Sarkar P; Samaddar S; Fensterseifer ICM; Farias-Junior C; Krishnamoorthy P; Shome BR; Franco OL; Haldar J
    PLoS One; 2017; 12(8):e0183263. PubMed ID: 28837596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biofilm prevention of gram-negative bacterial pathogens involved in periprosthetic infection by antibiotic-loaded calcium sulfate beads in vitro.
    Howlin RP; Winnard C; Frapwell CJ; Webb JS; Cooper JJ; Aiken SS; Stoodley P
    Biomed Mater; 2016 Dec; 12(1):015002. PubMed ID: 27910828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of Antibiotic Activity by a Novel Cationic Peptide: Potency and Spectrum of Activity of SPR741.
    Corbett D; Wise A; Langley T; Skinner K; Trimby E; Birchall S; Dorali A; Sandiford S; Williams J; Warn P; Vaara M; Lister T
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silver enhances antibiotic activity against gram-negative bacteria.
    Morones-Ramirez JR; Winkler JA; Spina CS; Collins JJ
    Sci Transl Med; 2013 Jun; 5(190):190ra81. PubMed ID: 23785037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding the potential of NAI-107 for treating serious ESKAPE pathogens: synergistic combinations against Gram-negatives and bactericidal activity against non-dividing cells.
    Brunati C; Thomsen TT; Gaspari E; Maffioli S; Sosio M; Jabes D; Løbner-Olesen A; Donadio S
    J Antimicrob Chemother; 2018 Feb; 73(2):414-424. PubMed ID: 29092042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of the colistin-rifampicin combination against colistin-resistant, carbapenemase-producing Gram-negative bacteria.
    Nastro M; Rodríguez CH; Monge R; Zintgraff J; Neira L; Rebollo M; Vay C; Famiglietti A
    J Chemother; 2014 Aug; 26(4):211-6. PubMed ID: 24070502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane-targeting, ultrashort lipopeptide acts as an antibiotic adjuvant and sensitizes MDR gram-negative pathogens toward narrow-spectrum antibiotics.
    Panjla A; Kaul G; Shukla M; Akhir A; Tripathi S; Arora A; Chopra S; Verma S
    Biomed Pharmacother; 2024 Jul; 176():116810. PubMed ID: 38823276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic Understanding Enables the Rational Design of Salicylanilide Combination Therapies for Gram-Negative Infections.
    Copp JN; Pletzer D; Brown AS; Van der Heijden J; Miton CM; Edgar RJ; Rich MH; Little RF; Williams EM; Hancock REW; Tokuriki N; Ackerley DF
    mBio; 2020 Sep; 11(5):. PubMed ID: 32934086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The polyamino-isoprenyl potentiator NV716 revives disused antibiotics against Gram-negative bacteria in broth, infected monocytes, or biofilms, by disturbing the barrier effect of their outer membrane.
    Wang G; Brunel JM; Rodriguez-Villalobos H; Bolla JM; Van Bambeke F
    Eur J Med Chem; 2022 Aug; 238():114496. PubMed ID: 35691172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of Tridecaptin-Antibiotic Conjugates with in Vivo Activity against Gram-Negative Bacteria.
    Cochrane SA; Li X; He S; Yu M; Wu M; Vederas JC
    J Med Chem; 2015 Dec; 58(24):9779-85. PubMed ID: 26636619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial and anti-biofilm activities of melittin and colistin, alone and in combination with antibiotics against Gram-negative bacteria.
    Dosler S; Karaaslan E; Alev Gerceker A
    J Chemother; 2016 Apr; 28(2):95-103. PubMed ID: 25801062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repurposing azithromycin and rifampicin against Gram-negative pathogens by combination with peptide potentiators.
    Baker KR; Jana B; Hansen AM; Vissing KJ; Nielsen HM; Franzyk H; Guardabassi L
    Int J Antimicrob Agents; 2019 Jun; 53(6):868-872. PubMed ID: 30447380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic Potentiation in Multidrug-Resistant Gram-Negative Pathogenic Bacteria by a Synthetic Peptidomimetic.
    Mood EH; Goltermann L; Brolin C; Cavaco LM; Nejad AJ; Yavari N; Frederiksen N; Franzyk H; Nielsen PE
    ACS Infect Dis; 2021 Aug; 7(8):2152-2163. PubMed ID: 34227804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and Chemical Screening Reveals Targets and Compounds to Potentiate Gram-Positive Antibiotics against Gram-Negative Bacteria.
    Klobucar K; Jardine E; Farha MA; MacKinnon MR; Fragis M; Nkonge B; Bhando T; Borrillo L; Tsai CN; Johnson JW; Coombes BK; Magolan J; Brown ED
    ACS Infect Dis; 2022 Oct; 8(10):2187-2197. PubMed ID: 36098580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amide side chain amphiphilic polymers disrupt surface established bacterial bio-films and protect mice from chronic Acinetobacter baumannii infection.
    Uppu DS; Samaddar S; Ghosh C; Paramanandham K; Shome BR; Haldar J
    Biomaterials; 2016 Jan; 74():131-43. PubMed ID: 26454051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outer Membrane Disruption Overcomes Intrinsic, Acquired, and Spontaneous Antibiotic Resistance.
    MacNair CR; Brown ED
    mBio; 2020 Sep; 11(5):. PubMed ID: 32963002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of XF-73, a novel antibacterial agent, against antibiotic-sensitive and -resistant Gram-positive and Gram-negative bacterial species.
    Farrell DJ; Robbins M; Rhys-Williams W; Love WG
    Int J Antimicrob Agents; 2010 Jun; 35(6):531-6. PubMed ID: 20346634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of gentamicin, vancomycin or amikacin combined with EDTA or l-arginine as lock therapy against a wide spectrum of biofilm-forming clinical strains isolated from catheter-related infections.
    Lebeaux D; Leflon-Guibout V; Ghigo JM; Beloin C
    J Antimicrob Chemother; 2015; 70(6):1704-12. PubMed ID: 25712314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of tigecycline and comparators against gram-negative bacteria isolated from a tertiary hospital in Alexandria, Egypt.
    Mohamed NM; Youssef AA
    Microb Drug Resist; 2011 Dec; 17(4):489-95. PubMed ID: 21875338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective labelling and eradication of antibiotic-tolerant bacterial populations in Pseudomonas aeruginosa biofilms.
    Chua SL; Yam JK; Hao P; Adav SS; Salido MM; Liu Y; Givskov M; Sze SK; Tolker-Nielsen T; Yang L
    Nat Commun; 2016 Feb; 7():10750. PubMed ID: 26892159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.